Gut bacteria cocktail aimed at superbug infections – trial pulled before start
NCT ID NCT06214403
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study planned to test a treatment called MET-2, a mix of gut bacteria, to help clear antibiotic-resistant germs from the body after a bloodstream infection. It was designed for adults not in intensive care who had a resistant infection. The trial was withdrawn before enrolling anyone, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTIBIOTIC RESISTANT INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sinai Health
Toronto, Ontario, M6G 1X5, Canada
-
Sunnybrook Health Sciences Centre
Toronto, Ontario, M4N 3M5, Canada
-
The Ottawa Hospital
Ottawa, Ontario, K1Y 4E9, Canada
-
University Health Network
Toronto, Ontario, M5G 1L7, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A 5-hour test may replace days of waiting for the right antibiotic in blood infections
- Antibiotic-Infused bone graft could slash infection risk in hip replacements
- Tiny study tracks bacteria as teeth vanish and implants arrive
- Could your workout change the germs in your mouth?
- C-Section babies may get a microbial boost from mom
- Could donor milk give late preterm babies a healthier start than formula?